A critical appraisal of the PETITE study report: Topical corticosteroids are safe and effective in the long-term treatment of infantile atopic dermatitis

Pediatrics

Volumn 136, Issue 5, 2015, Pages e1485-

  Weidinger, Stephan ^a   Baurecht, Hansjoerg ^b   Schmitt, Jochen ^c  

^a Schleswig Holstein University Hospital   (United States)

^b UKSH Kiel   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CORTICOSTEROID; PIMECROLIMUS; DERMATOLOGICAL AGENT; GLUCOCORTICOID;

ATOPIC DERMATITIS; BRONCHITIS; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ECZEMA; EPIDERMAL THICKNESS; HUMAN; IMPETIGO; INFANT; INFANTILE ATOPIC DERMATITIS; LETTER; LONG TERM CARE; PRIORITY JOURNAL; RHINOPHARYNGITIS; SKIN WATER LOSS; SKINFOLD THICKNESS; TREATMENT DURATION; DERMATITIS, ATOPIC; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; GLUCOCORTICOIDS; HUMANS; INFANT;

EID: 84947215020     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-2785A     Document Type: Letter

References (5)

1. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303(20):2058-2064
2. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3(8):e3081
3. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-2604
4. Food and Drug Administration; Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research. Draft guidance: guidance for industry non-inferiority clinical trials. Available at: www.fda.gov/downloads/Drugs/Guidances/UCM202140.pdf. Assessed May 20, 2015
5. Jensen JM, Pfeiffer S, Witt M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol. 2009; 123(5):1124-1133